How kēpos uses human milk oligosaccharides to help improve digestion

Q: Will HMOs help with bloating?

By selectively feeding Bifidobacterium and supporting a healthier gut environment, HMOs are associated with improved digestive comfort in adults. One trial in healthy adults showed favorable microbiota shifts with an HMO blend, though individual results may vary.

Q: Are the HMOs in kēpos dairy-free?

Yes. The HMOs in kēpos are produced by fermentation—not extracted from dairy—and are purified to be chemically identical to human milk oligosaccharides found in human milk. EFSA has issued multiple favorable safety opinions on fermentation-derived HMOs.

Q: Why include hmLF effera™ lactoferrin?

Lactoferrin supports gut and immune function through antimicrobial activity, iron-binding, and mucosal immune modulation—mechanisms that complement the microbiome-shaping effects of HMOs.

Q: How does this compare to bovine colostrum?

Adult data on bovine colostrum are mixed. Some studies show improved gut permeability in athletes, while conclusions outside that setting are less consistent. kēpos focuses on targeted, well-characterized human-milk bioactives with clear, specific mechanisms of action.

Why HMOs for digestion?

Human milk oligosaccharides (HMOs) are complex, selective carbohydrates that beneficial microbes—especially Bifidobacterium—love to consume. By feeding the “right” microbes, HMOs help tilt your microbiome toward a composition associated with less gas and bloating, better barrier integrity, and overall digestive ease. Reviews describe HMOs as shaping a bifidobacteria-rich microbiome and strengthening the epithelial barrier through metabolites and pH effects.¹

What the research says

Adults tolerate HMO blends and see bifidobacteria increases. In a placebo-controlled trial, healthy adults supplemented with 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT) showed increases in Bifidobacterium and favorable microbiota shifts.²
Reviews support microbiome and barrier benefits. Contemporary reviews summarize HMOs’ roles in promoting a protective, bifidobacteria-rich community and supporting barrier function—both relevant to digestive comfort.^{1, 3}
Emerging clinical and mechanistic data continue to grow. Additional syntheses and pilot work explore 2′-FL effects on GI quality-of-life measures and short-chain fatty acids in adult populations.⁴

How kēpos works

1) HMOs for digestive comfort

kēpos uses specific, fermentation-derived HMOs (like 2′-FL) that selectively feed beneficial microbes and help create a friendlier gut environment. This supports comfortable digestion by promoting a microbiome that resists opportunists and fosters a healthy gut lining.^{2, 1}

2) hmLF effera™ Lactoferrin for gut environment support

Lactoferrin, an iron-binding glycoprotein also native to human milk, contributes antimicrobial and immune-modulating activities that support the GI mucosa and overall gut environment—complementary to HMOs.^{5, 6, 7}

How this compares with bovine colostrum

Bovine colostrum research in adults is mixed: some athlete studies suggest permeability benefits, while broader outcomes vary. kēpos focuses on defined human-milk bioactives (HMOs + lactoferrin), with consistent identity and dosing.⁸

Is it dairy-free and safe?

The HMOs used today in foods and supplements (e.g., 2′-FL, LNnT, LNT, 3-FL) are typically produced by microbial fermentation and purified to be chemically identical to those found in human milk. Regulatory opinions and assessments have evaluated their safety for intended uses.^{9, 10, 11} As with any supplement, individuals with medical conditions or who are pregnant/breastfeeding should consult their clinician.

FAQ

Will HMOs help with bloating?

By selectively feeding Bifidobacterium and supporting a healthier gut environment, HMOs are associated with improved digestive comfort in adults. One trial in healthy adults showed favorable microbiota changes with an HMO blend; individual results vary.^{2, 1}

Are the HMOs in kēpos dairy-free?

Yes. The HMOs we use are produced by fermentation—not extracted from dairy proteins—and are purified to be chemically identical to HMOs found in human milk. EFSA has issued multiple favorable safety opinions on fermentation-derived HMOs.^{9, 10, 11}

Why include hmLF effera™ lactoferrin?

Lactoferrin supports the gut environment via antimicrobial and immune-modulating actions—complementary to HMO-driven microbiome shaping.^{5, 6, 7}

How does this compare to bovine colostrum?

Adult data on bovine colostrum show mixed results. Some studies note improved gut permeability in athletes, while conclusions outside that context are less consistent. We prioritize targeted, well-characterized human-milk bioactives with clear mechanisms.⁸

References

Dinleyici M, et al. Functional effects of human milk oligosaccharides (HMOs). Nutrients. 2023. PMC: PMC10026937
Elison E, et al. Oral supplementation of healthy adults with 2′-FL and LNnT: microbiota & GI outcomes. Benef Microbes. 2016. PMC: PMC5082288
Šuligoj T, et al. Effects of HMOs on the adult gut microbiota. Nutrients. 2020. PubMed: 32933181 / PMC: PMC7551690
Ryan JJ, et al. Impact of 2′-FL on gut microbiota & GI quality-of-life (pilot). Nutrients. 2021. PMC: PMC7998190
Donovan SM. Role of lactoferrin in GI and immune development. Nutr Rev. 2016. PubMed: 27234407
Conesa C, et al. The role of lactoferrin in intestinal health. Foods. 2023. PMC: PMC10304194
Liu N, et al. Functional role of lactoferrin in intestine mucosal immunity. Front Nutr. 2021. PMC: PMC8655231
Dziewiecka H, et al. Colostrum & gut permeability in athletes (systematic review). Nutrients. 2022. PMC: PMC9227274 / PubMed: 35745242
EFSA NDA Panel. Safety of 2′-fucosyllactose produced by fermentation as a novel food. 2023. EFSA Journal: EFSA 2023
EFSA NDA Panel. Safety of 3-fucosyllactose (fermentation-derived). 2022. PMC: PMC9131588
EFSA NDA Panel. Safety of lacto-N-tetraose (LNT) produced by microbial fermentation. 2022. EFSA Journal: 10.2903/j.efsa.2022.7242